The novel bio-SYNTAX scoring system for predicting the prognosis of patients undergoing percutaneous coronary intervention with left main coronary artery disease

BackgroundSimple and effective risk models incorporating biomarkers associated with left main coronary artery (LMCA) stenosis are limited. This study aimed to validate the novel Bio-Clinical SYNTAX score (Bio-CSS) incorporating N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with L...

Полное описание

Библиографические подробности

Главные авторы:	Jae Yong Yoon, Jang Hoon Lee, Hong Nyun Kim, Namkyun Kim, Se Yong Jang, Myung Hwan Bae, Dong Heon Yang, Hun Sik Park, Yongkeun Cho
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2022-09-01
Серии:	Frontiers in Cardiovascular Medicine
Предметы:	risk stratification N-terminal pro-B type natriuretic peptide left main coronary artery disease percutaneous coronary intervention drug eluting stent
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.912286/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!